Watchlist Manager

Watchlist

Price: 2 492 JPY -0.7% Market Closed

Market Cap: ¥1.2T

	Ono Pharmaceutical Co Ltd TSE:4528	JP

Balance Sheet

Currency: JPY

	Mar-2002	Mar-2003	Mar-2004	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	15 880	16 434	14 867	15 296	14 904	14 941	14 256	14 102	15 387	22 445	20 959	24 261	19 999	25 284	35 516	146 323	65 273	59 981	69 005	61 045	69 112	96 135	166 141	204 567
Cash Equivalents	15 880	16 434	14 867	15 296	14 904	14 941	14 256	14 102	15 387	22 445	20 959	24 261	19 999	25 284	35 516	146 323	65 273	59 981	69 005	61 045	69 112	96 135	166 141	204 567
Short-Term Investments	94 221	109 451	100 383	96 304	101 023	119 620	130 598	102 908	97 830	103 524	104 813	105 877	23 200	23 566	22 383	18 379	20 503	11 487	31 414	43 930	47 857	68 154	38 454	5 813
Total Receivables	39 321	38 066	39 322	43 577	42 119	42 058	41 096	39 471	31 612	36 695	37 848	37 817	127 139	120 898	137 012	73 255	81 196	76 285	76 834	84 269	99 788	114 396	136 066	139 007
Accounts Receivables	39 321	38 066	39 322	43 577	42 119	42 058	41 096	39 471	31 612	36 695	37 848	37 817	42 240	35 329	56 436	68 131	70 391	67 861	68 957	74 085	92 697	108 360	129 007	128 122
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	84 899	85 569	80 576	5 124	10 805	8 424	7 877	10 184	7 091	6 036	7 059	10 885
Inventory	9 747	9 241	10 093	9 027	9 346	9 300	9 970	10 057	14 625	13 046	18 636	23 408	24 232	25 805	23 232	25 334	31 290	32 821	32 906	39 151	41 817	44 814	48 629	74 864
Other Current Assets	7 872	8 726	14 292	15 364	14 711	14 509	16 132	14 015	22 385	15 656	19 979	23 378	957	2 312	5 430	7 742	11 202	14 043	15 063	19 247	22 692	21 602	24 306	30 853
Total Current Assets	167 041	181 918	178 957	179 568	182 103	200 428	212 052	180 553	181 839	191 366	202 235	214 741	195 527	197 865	223 573	271 033	209 464	194 617	225 222	247 642	281 266	345 101	413 596	455 104
PP&E Net	53 013	59 768	61 879	59 215	55 773	53 215	51 261	50 539	50 008	48 615	47 979	49 630	59 147	70 754	80 094	83 659	94 321	108 870	114 628	113 866	112 131	108 420	104 752	105 721
PP&E Gross	53 013	59 768	61 879	59 215	55 773	53 215	51 261	50 539	50 008	48 615	47 979	49 630	59 147	70 754	80 094	83 659	94 321	108 870	114 628	113 866	112 131	108 420	104 752	105 721
Accumulated Depreciation	44 354	46 860	50 103	53 528	56 306	57 337	59 427	61 288	63 592	65 560	66 597	68 595	77 403	78 807	79 641	81 218	82 539	84 948	88 766	93 905	100 787	107 370	114 005	120 389
Intangible Assets	1 656	1 630	1 462	1 297	1 169	1 091	1 041	1 032	866	955	994	1 383	22 690	33 913	38 324	45 237	55 715	63 059	66 436	68 285	64 734	69 134	57 288	330 041
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21 186
Note Receivable	218	200	144	94	23	21	21	18	17	15	15	12	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	112 073	97 771	161 587	190 810	257 268	244 771	207 516	178 333	190 628	167 953	168 690	180 200	189 368	213 185	183 378	176 687	188 919	171 589	137 778	146 908	125 154	123 423	121 262	88 558
Other Long-Term Assets	22 473	21 362	9 020	8 284	8 103	5 283	5 443	10 797	9 862	15 532	16 500	9 606	19 230	8 871	15 081	40 845	60 807	116 921	129 380	168 727	155 918	236 359	216 770	63 436
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21 186
Total Assets	356 474 N/A	362 649 +2%	413 049 +14%	439 268 +6%	504 439 +15%	504 809 +0%	477 334 -5%	421 272 -12%	433 220 +3%	424 436 -2%	436 413 +3%	455 572 +4%	485 962 +7%	524 588 +8%	540 450 +3%	617 461 +14%	609 226 -1%	655 056 +8%	673 444 +3%	745 428 +11%	739 203 -1%	882 437 +19%	913 668 +4%	1 064 046 +16%
Liabilities
Accounts Payable	2 747	6 825	3 052	2 662	3 126	2 969	3 044	3 423	2 344	5 324	5 767	4 243	10 836	3 779	9 793	7 128	5 623	6 297	6 398	7 640	8 991	8 033	10 742	15 007
Accrued Liabilities	3 747	4 000	4 094	3 993	4 374	4 116	3 968	3 884	3 959	4 076	4 255	4 388	0	0	0	0	0	0	0	0	0	0	0	0
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	26	37	26	84	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	8	8	6	5	1	1	1	1	1	1	1	101	508	261	291	398	308	435	2 188	2 023	2 301	2 490	2 310	33 178
Other Current Liabilities	19 899	18 335	27 744	20 742	18 369	20 770	22 394	18 149	17 135	16 793	21 018	17 054	16 476	30 931	42 073	75 381	62 454	76 418	82 743	84 070	54 634	112 406	90 572	100 111
Total Current Liabilities	26 401	29 168	34 896	27 402	25 870	27 856	29 407	25 457	23 439	26 194	31 041	25 786	27 820	34 997	52 194	82 933	68 469	83 150	91 329	93 733	65 926	122 929	103 624	148 296
Long-Term Debt	144	136	101	84	20	18	17	15	14	12	11	134	485	338	534	553	320	1 765	6 173	7 030	6 501	6 678	6 552	113 500
Deferred Income Tax	0	0	0	1 729	18 745	20 983	8 270	2 961	2 966	2 932	2 591	5 069	1 002	1 156	885	881	1 016	1 053	1 059	1 052	1 009	983	1 013	10 817
Minority Interest	1 578	1 799	2 050	2 167	2 472	2 800	3 235	3 419	3 629	3 860	3 076	3 301	4 397	4 638	4 862	5 101	5 228	5 386	5 538	5 610	5 768	5 944	5 644	5 751
Other Liabilities	23 294	17 455	18 583	16 456	13 702	9 147	9 378	2 800	691	724	1 802	1 293	4 659	12 884	10 582	8 883	9 802	6 352	6 861	3 870	4 093	4 035	3 875	3 230
Total Liabilities	51 417 N/A	48 558 -6%	55 630 +15%	47 838 -14%	60 809 +27%	60 804 0%	50 307 -17%	34 652 -31%	30 739 -11%	33 722 +10%	38 521 +14%	35 583 -8%	38 363 +8%	54 013 +41%	69 057 +28%	98 351 +42%	84 835 -14%	97 706 +15%	110 960 +14%	111 295 +0%	83 297 -25%	140 569 +69%	120 708 -14%	281 594 +133%
Equity
Common Stock	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358	17 358
Retained Earnings	282 832	304 354	330 298	364 238	392 290	404 061	421 278	422 565	430 870	435 536	425 787	430 824	456 809	449 690	452 983	492 237	459 985	499 088	524 605	62 299	644 754	709 890	768 183	790 908
Additional Paid In Capital	17 002	17 002	17 002	17 002	17 002	17 002	17 079	17 079	17 079	17 079	17 079	17 079	17 080	17 080	17 103	17 144	17 175	17 202	17 229	17 231	17 241	17 080	17 458	17 458
Unrealized Security Profit/Loss	2 002	4 145	13 363	15 115	39 275	30 242	8 194	6 752	784	4 776	2 852	13 874	14 952	44 583	0	51 035	67 416	61 170	47 567	61 412	49 535	49 529	49 300	32 843
Treasury Stock	10 147	20 467	20 590	22 273	22 311	24 709	36 860	63 425	63 439	74 219	59 204	59 214	59 274	59 308	0	59 382	38 148	38 151	44 737	44 705	74 683	54 161	63 233	63 063
Other Equity	15	8	12	10	16	50	21	203	173	266	276	68	674	1 172	813	718	605	683	462	520 538	1 701	2 172	3 894	13 052
Total Equity	305 058 N/A	314 094 +3%	357 419 +14%	391 430 +10%	443 630 +13%	444 004 +0%	427 028 -4%	386 622 -9%	402 479 +4%	390 712 -3%	397 892 +2%	419 989 +6%	447 599 +7%	470 575 +5%	471 393 +0%	519 110 +10%	524 391 +1%	557 350 +6%	562 484 +1%	634 133 +13%	655 906 +3%	741 868 +13%	792 960 +7%	782 452 -1%
Total Liabilities & Equity	356 475 N/A	362 652 +2%	413 049 +14%	439 268 +6%	504 439 +15%	504 808 +0%	477 335 -5%	421 274 -12%	433 218 +3%	424 434 -2%	436 413 +3%	455 572 +4%	485 962 +7%	524 588 +8%	540 450 +3%	617 461 +14%	609 226 -1%	655 056 +8%	673 444 +3%	745 428 +11%	739 203 -1%	882 437 +19%	913 668 +4%	1 064 046 +16%
Shares Outstanding
Common Shares Outstanding	602	589	589	587	587	577	567	544	544	530	530	530	530	530	530	530	514	514	499	499	488	488	470	470

Income Statement Balance Sheet Cash Flow Statement

Ono Pharmaceutical Co Ltd
TSE:4528

Balance Sheet

Balance Sheet Decomposition
Ono Pharmaceutical Co Ltd

Balance Sheet
Ono Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Ono Pharmaceutical Co Ltd TSE:4528

Balance Sheet

Balance Sheet Decomposition Ono Pharmaceutical Co Ltd

Balance Sheet Ono Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Ono Pharmaceutical Co Ltd
TSE:4528

Balance Sheet Decomposition
Ono Pharmaceutical Co Ltd

Balance Sheet
Ono Pharmaceutical Co Ltd